The gathering brought together ministers, investors, industry leaders, and development partners to unlock fresh capital for the sector.
The newly operational committee will spearhead the development and implementation of evidence-based food policies designed to protect Kenyan consumers.
This initiative aligns with the Universal Health Coverage (UHC) agenda and seeks to transform regional facilities into dependable referral hubs that bring advanced cancer care closer to communities across the country.
The validation follows a Joint External Evaluation conducted in September 2024, which assessed the country’s capacity to prevent, detect, and respond to public health threats.
This strategic shift addresses mounting concerns about regulatory compliance and workforce development in the country’s healthcare sector.
The Pharmacy and Poisons Board has approved both the 300 mg tablet and 464 mg injectable solution forms of Lenacapavir for use as pre-exposure prophylaxis (PrEP).
CS Duale demanded the swift removal of all substandard, falsified, poor-quality, counterfeit, and unregistered medicines from the Kenyan market.